Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk Boot

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 13, 2006
Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancerEdwin P M Jansen, Mark P Saunders, Henk Boot, et al.
Annals of Surgical Oncology|August 29, 2014
Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a dutch cohort studyJurriën Stiekema, Anouk K Trip, Edwin P M Jansen, et al.
American Journal of Clinical Oncology|June 22, 2010
Chemoradiation for esophageal cancer: institutional experience with three different regimensEwout F W Courrech Staal, Berthe M P Aleman, Marie-Louise F van Velthuysen, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 21, 2011
[Interaction between clopidogrel and proton pump inhibitors]Ankie M Harmsze, Anthonius de Boer, Henk Boot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumorsWandena S Siegel-Lakhai, Jos H Beijnen, Walter L Vervenne, et al.
Annals of Surgical Oncology|September 25, 2009
Outcome of low-volume surgery for esophageal cancer in a high-volume referral centerEwout F W Courrech Staal, Frits van Coevorden, Annemieke Cats, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2014
Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapyJohan L Dikken, Daniel G Coit, Raymond E Baser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost AnalysisMaarten J Deenen, Didier Meulendijks, Annemieke Cats, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancerJohan L Dikken, Edwin P M Jansen, Annemieke Cats, et al.
BMC Cancer|August 4, 2011
Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)Johan L Dikken, Johanna W van Sandick, H A Maurits Swellengrebel, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|December 13, 2006
Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancerEdwin P M Jansen, Mark P Saunders, Henk Boot, et al.
Annals of Surgical Oncology|August 29, 2014
Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a dutch cohort studyJurriën Stiekema, Anouk K Trip, Edwin P M Jansen, et al.
American Journal of Clinical Oncology|June 22, 2010
Chemoradiation for esophageal cancer: institutional experience with three different regimensEwout F W Courrech Staal, Berthe M P Aleman, Marie-Louise F van Velthuysen, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 21, 2011
[Interaction between clopidogrel and proton pump inhibitors]Ankie M Harmsze, Anthonius de Boer, Henk Boot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumorsWandena S Siegel-Lakhai, Jos H Beijnen, Walter L Vervenne, et al.
Annals of Surgical Oncology|September 25, 2009
Outcome of low-volume surgery for esophageal cancer in a high-volume referral centerEwout F W Courrech Staal, Frits van Coevorden, Annemieke Cats, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2014
Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapyJohan L Dikken, Daniel G Coit, Raymond E Baser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost AnalysisMaarten J Deenen, Didier Meulendijks, Annemieke Cats, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancerJohan L Dikken, Edwin P M Jansen, Annemieke Cats, et al.
BMC Cancer|August 4, 2011
Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)Johan L Dikken, Johanna W van Sandick, H A Maurits Swellengrebel, et al.
Pageof 6